This Market Report “Global Assisted Reproductive Technology Market Research Report 2018”provides detailed insight covering all important parameters including Development Trends, Challenges, Opportunities, Key Manufacturers and Competitive Analysis.
Assisted reproductive technology (ART) market is gaining precedence owing to its ability to cure women having infertility issues. The assisted reproductive technology industry includes fertility medication, in vitro fertilization and surrogacy.
The global assisted reproductive technology market can experience a 10% CAGR during the forecast period (2018-2023), reveals Market Research Future (MRFR) in a report that covers drivers of the said market and segments in detail. Infertility cases are on the rise, that too, at an alarming rate.
This has been triggered by a sedentary lifestyle, obesity, ovulation disorder, unhealthy diet, increasing intake of tobacco & alcohol, and chronic diseases.
However, lower success rate, high cost, chances of birth defects, and side effects associated with hysterectomy procedures are some issues that can pose hurdles to stop the regular market growth during the forecast period.
GET FREE SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/6359
Merck launches two new products QBOX IVF, and the new Geri Assess 2.0, to increase fertility opportunities for patients. With an intention to become the choicest treatment partner for IVF stakeholders and assisted reproductive treatment (ART) clinics, the company has been innovating and improvising their products for a better result.
The global assisted reproductive technology (ART) market can be segmented by diagnosis, type, end-user.
By diagnosis, the assisted reproductive technology market can be segmented into ovulation testing, hysterosalpingography, ovarian reserve testing, genetic testing, other hormone testing, and imaging tests.
Based on type, the assisted reproductive technology market includes Ovulation Induction (OI), Artificial Insemination (AI), Donor Conception, In-Vitro Fertilization (IVF), Gamete Intrafallopian Transfer (GIFT), Intracytoplasmic Sperm Injection (ICSI), Preimplantation Genetic Diagnosis (PGD) and Surrogacy.
Based on end-user, the assisted reproductive technology market can be segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and IVF centers and others.
Region-specific analysis of the assisted reproductive technology market includes Europe, the Americas, Asia Pacific (APAC), and Middle East & Africa (MEA).
Europe, at present, is dominating the market as the region is gaining substantially from increasing innovations in clinical practice and access to fertility treatment in this region. Infrastructural standard related to the healthcare sector can also be touted as influencers.
The Americas is assuming the second spot, and the market scenario is going to remain the same during the forecast period. Increasing cases of cancer can be seen as a potential market booster. The APAC market is projected to become the fastest growing segment during the forecast period.
Rising cases of, obesity and diabetes can be taken into consideration while judging the parameters of the regional growth. The MEA market is expected to generate the least amount of share owing to stringent government policies and low per capita income.
Merger, acquisition, collaboration, partnership, and other methods are some tactical moves that the companies employ to sustain and grow. This, as a consequence, also helps the market in its growth.
For instance, California Cryobank and Cord Blood Registry have entered into a definitive agreement that will work as a new entity under California Cryobank Life Sciences platform to bring in the best of domestic and international opportunities for expansion and better the research & development sector of donor reproductive tissue and newborn stem cell industries.
Some of the key players in the global assisted reproductive technology (ART) market are Anecova, Origio, California Cryobank, Cosmos Biomedical Limited, Cryolab Ltd., Parallabs, OvaScience, Microm Ltd., Merck KGaA, Cooper Surgical, Inc, Bloom IVF Centre, Ferring Pharmaceuticals, European Sperm Bank, Irvine Scientific and Hamilton Throne Ltd.
BROWSE COMPLETE 90 PAGES PREMIUM RESEARCH REPORT ENABLED WITH RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/assisted-reproductive-technology-market-6359
Major Points form Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Assisted Reproductive Technology Market, By Type
Chapter 7. Global Assisted Reproductive Technology Market, By Treatment
Chapter 8 Global Assisted Reproductive Technology Market, By End User
Chapter 9. Global Assisted Reproductive Technology Market, By Region
Chapter 10 Company Landscape
Chapter 11 Company Profiles
Chapter 12 MRFR Conclusion
Chapter 13 Appendix
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Name: Market Research Future
Organization: Market Research Future
Address: Office No. 528, Amanora Chambers
Phone: +1 646 845 9312
For more information, please visit https://www.marketresearchfuture.com/reports/rheumatoid-arthritis-market-1658
Release ID: 440562